Dr. Joe A. Cates, MD

Dr. Cates practices at Kansas City Vascular & General Surgery Group in Leawood, Kansas.

Dr. Cates' NPI, 1316942972, was assigned on June 20, 2005. Dr. Cates graduated from UMKC School of Medicine in 1987. Dr. Cates holds Kansas license 0425089.

Dr. Cates' primary practice is Kansas City Vascular & General Surgery Group, at 5100 W 110th St, Leawood, KS 66211 in Johnson County. The practice phone is (913) 754-2800.

Dr. Cates' primary practice is Kansas City Vascular & General Surgery Group in Leawood, Kansas. Dr. Cates is also affiliated with Research Medical Center. The medical group on file is Kansas City Vascular & General Surgery. Dmand AI also links Dr. Cates to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cates practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Cates' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Cates is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Cates' licenses on file in 3 states: Kansas, California and Missouri.

Dmand AI lists carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Cates treats.

CMS data shows 2,052 Medicare services from Dr. Cates across 29 procedure codes in 2024, for 823 Medicare patients. Medicare paid $165,362 for them.

CMS counts 823 Medicare patients who saw Dr. Cates in 2024. The largest group is 65 to 74, with 322 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cates' median patient age at 73, with 47% women.

In 2024, Dr. Cates wrote 315 Medicare Part D claims for 128 patients. 93% of them were for generic drugs. CMS names the drug for 275 of them, across 4 drugs with 11 or more claims each, at $4,014 in total drug cost. In 2023, CMS named 255 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cates for performance year 2024, reported as part of a group. Dr. Cates accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Cates, more than 72% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Cates in 2024. The most frequent topics are Gallbladder, Sciuridae and Chlorides. Dr. Cates has published most often in Ann Surg. Dr. Cates' most frequent co-authors are Dan I. Giurgiu, MD, Seth Douglas Strichartz, MD and Jay K. Dhiman, MD.

CMS Open Payments shows 345 general payments to Dr. Cates from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Endologix, Inc. paid the most, $10,074.

Dmand AI lists 4 awards for Dr. Cates, most recently Regional Top Doctor in 2014.

Dr. Cates graduated from UMKC School of Medicine in 1987. Dr. Cates is a member of ACS.

Dr. Cates is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.